Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Acrodermatitis Continua of Hallopeau.

Korman AM, Rzepka PV, Sopkovich JA.

JAMA Dermatol. 2018 Oct 3. doi: 10.1001/jamadermatol.2018.3350. [Epub ahead of print] No abstract available.

PMID:
30285064
2.

Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma.

Harris-Bookman S, Mathios D, Martin AM, Xia Y, Kim E, Xu H, Belcaid Z, Polanczyk M, Barberi T, Theodros D, Kim J, Taube JM, Burger PC, Selby M, Taitt C, Korman A, Ye X, Drake CG, Brem H, Pardoll DM, Lim M.

Int J Cancer. 2018 Sep 24. doi: 10.1002/ijc.31661. [Epub ahead of print]

PMID:
30248181
3.

Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes.

Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA.

J Am Acad Dermatol. 2018 Oct;79(4):617-633. doi: 10.1016/j.jaad.2018.01.023. Review.

PMID:
30241624
4.

Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up.

Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A.

J Am Acad Dermatol. 2018 Oct;79(4):599-614. doi: 10.1016/j.jaad.2018.01.020. Review.

PMID:
30241623
5.

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.

Hung AL, Maxwell R, Theodros D, Belcaid Z, Mathios D, Luksik AS, Kim E, Wu A, Xia Y, Garzon-Muvdi T, Jackson C, Ye X, Tyler B, Selby M, Korman A, Barnhart B, Park SM, Youn JI, Chowdhury T, Park CK, Brem H, Pardoll DM, Lim M.

Oncoimmunology. 2018 May 24;7(8):e1466769. doi: 10.1080/2162402X.2018.1466769. eCollection 2018.

6.

Applying to dermatology residency: An ethical approach to an inherently unethical process.

Korman AM, Grant-Kels JM.

Int J Womens Dermatol. 2018 May 26;4(3):176-178. doi: 10.1016/j.ijwd.2018.01.001. eCollection 2018 Sep. No abstract available.

7.

Subclinical granulomas in benign skin lesions heralding the onset of BRAF and MEK inhibitor-associated granulomatous dermatitis in a patient with metastatic melanoma.

Korman AM, Nisar MS, Somach SC.

JAAD Case Rep. 2018 Aug 16;4(7):722-724. doi: 10.1016/j.jdcr.2018.05.011. eCollection 2018 Aug. No abstract available.

8.

CD226 opposes TIGIT to disrupt Tregs in melanoma.

Fourcade J, Sun Z, Chauvin JM, Ka M, Davar D, Pagliano O, Wang H, Saada S, Menna C, Amin R, Sander C, Kirkwood JM, Korman AJ, Zarour HM.

JCI Insight. 2018 Jul 25;3(14). pii: 121157. doi: 10.1172/jci.insight.121157. [Epub ahead of print]

9.

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.

Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG.

Clin Cancer Res. 2018 Oct 15;24(20):5058-5071. doi: 10.1158/1078-0432.CCR-17-3427. Epub 2018 Jun 13.

PMID:
29898992
10.

Biological effects of mixed-ion beams. Part 1: Effect of irradiation of the CHO-K1 cells with a mixed-ion beam containing the carbon and oxygen ions.

Czub J, Banaś D, Braziewicz J, Buraczewska I, Jaskóła M, Kaźmierczak U, Korman A, Lankoff A, Lisowska H, Szefliński Z, Wojewódzka M, Wójcik A.

Appl Radiat Isot. 2018 Sep;139:304-309. doi: 10.1016/j.apradiso.2018.05.028. Epub 2018 May 30.

PMID:
29883949
11.

An Unusual Cause of Rectal Bleeding in a 34-Year-Old Male.

Kohli M, Charilaou P, Enjamuri D, Rosenthal M, Korman A.

Am J Gastroenterol. 2018 Jul;113(7):1055-1056. doi: 10.1038/s41395-018-0096-6. Epub 2018 Jun 8. No abstract available.

PMID:
29880967
12.

An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients.

Colston E, Grasela D, Gardiner D, Bucy RP, Vakkalagadda B, Korman AJ, Lowy I.

PLoS One. 2018 Jun 7;13(6):e0198158. doi: 10.1371/journal.pone.0198158. eCollection 2018.

13.

Limits on reliable information flows through stochastic populations.

Boczkowski L, Natale E, Feinerman O, Korman A.

PLoS Comput Biol. 2018 Jun 6;14(6):e1006195. doi: 10.1371/journal.pcbi.1006195. eCollection 2018 Jun. Erratum in: PLoS Comput Biol. 2018 Aug 9;14(8):e1006404.

14.

The Hfq chaperone helps the ribosome mature.

Sharma IM, Korman A, Woodson SA.

EMBO J. 2018 Jun 1;37(11). pii: e99616. doi: 10.15252/embj.201899616. Epub 2018 May 15. No abstract available.

PMID:
29764978
15.

Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites.

Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael LL, Loibner H, Gillies SD, Korman AJ, Erbe AK, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM.

Cancer Immunol Res. 2018 Jul;6(7):825-834. doi: 10.1158/2326-6066.CIR-17-0353. Epub 2018 May 10.

PMID:
29748391
16.

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors.

Crosby EJ, Wei J, Yang XY, Lei G, Wang T, Liu CX, Agarwal P, Korman AJ, Morse MA, Gouin K, Knott SRV, Lyerly HK, Hartman ZC.

Oncoimmunology. 2018 Jan 19;7(5):e1421891. doi: 10.1080/2162402X.2017.1421891. eCollection 2018.

17.

Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.

Nicolau JC, Furtado RHM, Silva SA, Rochitte CE, Rassi A Jr, Moraes JBMC Jr, Quintella E, Costantini CR, Korman APM, Mattos MA, Castello HJ Jr, Caixeta A, Dohmann HFR, de Carvalho ACC; MiHeart/AMI Investigators.

Clin Cardiol. 2018 Mar;41(3):392-399. doi: 10.1002/clc.22882. Epub 2018 Mar 22.

18.

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models.

Bezman NA, Jhatakia A, Kearney AY, Brender T, Maurer M, Henning K, Jenkins MR, Rogers AJ, Neeson PJ, Korman AJ, Robbins MD, Graziano RF.

Blood Adv. 2017 May 8;1(12):753-765. doi: 10.1182/bloodadvances.2017004382. eCollection 2017 May 9.

19.

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models.

Lewis KE, Selby MJ, Masters G, Valle J, Dito G, Curtis WR, Garcia R, Mink KA, Waggie KS, Holdren MS, Grosso JF, Korman AJ, Jure-Kunkel M, Dillon SR.

Oncoimmunology. 2017 Oct 4;7(1):e1377873. doi: 10.1080/2162402X.2017.1377873. eCollection 2017.

20.

Does Digital Rectal Examination Predict Hospital Admission and Resource Utilization Rate in Patients with Acute Gastrointestinal Bleeding with Bright Red Blood Per Rectum?

Charilaou P, Korman A, Pitchumoni CS, Broder A.

Am J Med. 2018 Jan;131(1):e31. doi: 10.1016/j.amjmed.2017.08.008. No abstract available.

PMID:
29224616
21.

Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model.

Shen YC, Ghasemzadeh A, Kochel CM, Nirschl TR, Francica BJ, Lopez-Bujanda ZA, Carrera Haro MA, Tam A, Anders RA, Selby MJ, Korman AJ, Drake CG.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):113-125. doi: 10.1038/s41391-017-0013-x. Epub 2017 Dec 4.

22.

CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes.

Aznar MA, Labiano S, Diaz-Lagares A, Molina C, Garasa S, Azpilikueta A, Etxeberria I, Sanchez-Paulete AR, Korman AJ, Esteller M, Sandoval J, Melero I.

Cancer Immunol Res. 2018 Jan;6(1):69-78. doi: 10.1158/2326-6066.CIR-17-0159. Epub 2017 Nov 13.

PMID:
29133290
23.

Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype.

Okada SL, Simmons RM, Franke-Welch S, Nguyen TH, Korman AJ, Dillon SR, Gilbertson DG.

Cell Immunol. 2018 Jan;323:49-58. doi: 10.1016/j.cellimm.2017.10.014. Epub 2017 Oct 31.

PMID:
29103587
24.

Novel mouse models of hepatic artery infusion.

Kim M, Fisher DT, Powers CA, Gabriel EM, Korman AM, Sexton S, Gudkov AV, Skitzki JJ.

J Surg Res. 2017 Nov;219:25-32. doi: 10.1016/j.jss.2017.05.083. Epub 2017 Jun 21.

PMID:
29078890
25.

Frequent skin examinations in patients with actinic keratoses: Ethical, financial, and moral implications.

Milam P, Korman A, Kaffenberger J.

J Am Acad Dermatol. 2017 Nov;77(5):985-987. doi: 10.1016/j.jaad.2017.03.005. No abstract available.

PMID:
29029915
26.

Outcomes From U.S. Military-Supported Overseas Training Rotations in Tropical Medicine and Global Health, 2006-2015.

Mancuso JD, Garges EC, Hickey PW, Coldren RL, Korman AK, Keep LW, DeFraites RF, Sanchez JL.

Mil Med. 2017 Sep;182(9):e1796-e1801. doi: 10.7205/MILMED-D-16-00408.

PMID:
28885939
27.

A novel technique for biliary polypectomy.

D'Souza LS, Korman A, Benias PC, Carr-Locke DL.

Endoscopy. 2017 Oct;49(10):E244-E245. doi: 10.1055/s-0043-114408. Epub 2017 Jul 31. No abstract available.

PMID:
28759924
28.

Percutaneous endoscopic necrosectomy.

D'Souza LS, Korman A, Carr-Locke DL, Benias PC.

Endoscopy. 2017 Oct;49(10):E242-E243. doi: 10.1055/s-0043-114407. Epub 2017 Jul 18. No abstract available.

PMID:
28719929
29.

Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.

Ramagopal UA, Liu W, Garrett-Thomson SC, Bonanno JB, Yan Q, Srinivasan M, Wong SC, Bell A, Mankikar S, Rangan VS, Deshpande S, Korman AJ, Almo SC.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4223-E4232. doi: 10.1073/pnas.1617941114. Epub 2017 May 8.

30.

Viral exanthems: An update on laboratory testing of the adult patient.

Korman AM, Alikhan A, Kaffenberger BH.

J Am Acad Dermatol. 2017 Mar;76(3):538-550. doi: 10.1016/j.jaad.2016.08.034. Epub 2016 Oct 26. Review.

PMID:
28413059
31.

Masterful Antibodies: Checkpoint Blockade.

Lonberg N, Korman AJ.

Cancer Immunol Res. 2017 Apr;5(4):275-281. doi: 10.1158/2326-6066.CIR-17-0057. Review.

32.

DoD-Supported Overseas Training Rotations in Tropical Medicine and Global Health, 2000-2015.

Mancuso JD, Hickey PW, Coldren RL, Korman AK, Keep LW, DeFraites RF, Smith M, Mancuso LJ, Sanchez JL.

Mil Med. 2017 Mar;182(3):e1719-e1725. doi: 10.7205/MILMED-D-16-00108.

PMID:
28290949
33.

Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma.

Korman AM, Tyler KH, Kaffenberger BH.

Int J Dermatol. 2017 Apr;56(4):e75-e77. doi: 10.1111/ijd.13513. Epub 2017 Jan 19. No abstract available.

PMID:
28102540
34.

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape.

Noguchi T, Ward JP, Gubin MM, Arthur CD, Lee SH, Hundal J, Selby MJ, Graziano RF, Mardis ER, Korman AJ, Schreiber RD.

Cancer Immunol Res. 2017 Feb;5(2):106-117. doi: 10.1158/2326-6066.CIR-16-0391. Epub 2017 Jan 10.

35.

Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.

Rakhmilevich AL, Felder M, Lever L, Slowinski J, Rasmussen K, Hoefges A, Van De Voort TJ, Loibner H, Korman AJ, Gillies SD, Sondel PM.

J Immunol. 2017 Feb 15;198(4):1575-1584. doi: 10.4049/jimmunol.1601255. Epub 2017 Jan 6.

36.

Individual versus collective cognition in social insects.

Feinerman O, Korman A.

J Exp Biol. 2017 Jan 1;220(Pt 1):73-82. doi: 10.1242/jeb.143891. Review.

37.

Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia.

Korman AM, Hastings JG, Byrd JC, Kaffenberger BH.

JAMA Dermatol. 2017 Jan 1;153(1):108-110. doi: 10.1001/jamadermatol.2016.3355. No abstract available.

PMID:
27892987
38.

Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.

Selby MJ, Engelhardt JJ, Johnston RJ, Lu LS, Han M, Thudium K, Yao D, Quigley M, Valle J, Wang C, Chen B, Cardarelli PM, Blanset D, Korman AJ.

PLoS One. 2016 Nov 18;11(11):e0167251. doi: 10.1371/journal.pone.0167251. eCollection 2016.

39.

A locally-blazed ant trail achieves efficient collective navigation despite limited information.

Fonio E, Heyman Y, Boczkowski L, Gelblum A, Kosowski A, Korman A, Feinerman O.

Elife. 2016 Nov 5;5. pii: e20185. doi: 10.7554/eLife.20185.

40.

Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich Tumor.

Ngiow SF, Young A, Blake SJ, Hill GR, Yagita H, Teng MW, Korman AJ, Smyth MJ.

Cancer Res. 2016 Nov 1;76(21):6266-6277. Epub 2016 Sep 9.

41.

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop.

Houot R, Gaulard P, Schreiber R, Mellman I, Lambotte O, Coulie PG, Fest T, Korman A, Levy R, Shipp M, Tarte K, Kohrt H, Marabelle A, Ansell S, Watier H, van Elsas A, Balakumaran A, Arce Vargas F, Quezada SA, Salles G, Olive D.

Oncoimmunology. 2016 May 19;5(7):e1186323. doi: 10.1080/2162402X.2016.1186323. eCollection 2016 Jul.

42.

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.

Selby MJ, Engelhardt JJ, Johnston RJ, Lu LS, Han M, Thudium K, Yao D, Quigley M, Valle J, Wang C, Chen B, Cardarelli PM, Blanset D, Korman AJ.

PLoS One. 2016 Sep 9;11(9):e0161779. doi: 10.1371/journal.pone.0161779. eCollection 2016. Erratum in: PLoS One. 2016 Nov 18;11(11):e0167251.

43.

Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement.

Dahan R, Barnhart BC, Li F, Yamniuk AP, Korman AJ, Ravetch JV.

Cancer Cell. 2016 Jun 13;29(6):820-831. doi: 10.1016/j.ccell.2016.05.001. Epub 2016 Jun 2.

44.

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.

Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, Carmichael LL, Yang RK, Armstrong EA, Huang S, Navid F, Gillies SD, Korman A, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM.

Cancer Res. 2016 Jul 1;76(13):3929-41. doi: 10.1158/0008-5472.CAN-15-2644. Epub 2016 May 6.

45.

The Human Vaccines Project: A roadmap for cancer vaccine development.

Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Dranoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ, Kvistborg P, Melief C, Mellman I, Palucka AK, Redchenko I, Robins H, Sallusto F, Schenkelberg T, Schoenberger S, Sosman J, Türeci Ö, Van den Eynde B, Koff W, Coukos G.

Sci Transl Med. 2016 Apr 13;8(334):334ps9. doi: 10.1126/scitranslmed.aaf0685. Review.

PMID:
27075624
46.

Oral tofacitinib for the treatment of adults with moderate to severe chronic plaque psoriasis.

Korman AM, Hill D, Alikhan A, Feldman SR.

Expert Rev Clin Pharmacol. 2016 Mar 7:1-15. [Epub ahead of print]

PMID:
26881913
47.

TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, Liegler T, Mitchell BI, Hecht FM, Ostrowski M, Shikuma CM, Hansen SG, Maurer M, Korman AJ, Deeks SG, Sacha JB, Ndhlovu LC.

PLoS Pathog. 2016 Jan 7;12(1):e1005349. doi: 10.1371/journal.ppat.1005349. eCollection 2016 Jan.

48.

Impact and management of depression in psoriasis patients.

Korman AM, Hill D, Alikhan A, Feldman SR.

Expert Opin Pharmacother. 2016;17(2):147-52. doi: 10.1517/14656566.2016.1128894. Epub 2016 Jan 4. No abstract available.

PMID:
26641936
49.

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab.

Koguchi Y, Hoen HM, Bambina SA, Rynning MD, Fuerstenberg RK, Curti BD, Urba WJ, Milburn C, Bahjat FR, Korman AJ, Bahjat KS.

Cancer Res. 2015 Dec 1;75(23):5084-92. doi: 10.1158/0008-5472.CAN-15-2303.

50.

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.

Dahan R, Sega E, Engelhardt J, Selby M, Korman AJ, Ravetch JV.

Cancer Cell. 2015 Oct 12;28(4):543. doi: 10.1016/j.ccell.2015.09.011. Epub 2015 Oct 12. No abstract available.

Supplemental Content

Loading ...
Support Center